Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 7Pancreatic Neoplasms 3Uterine Cervical Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Gastric Adenocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Gemcitabine 153Fluorouracil 45Capecitabine 45130-nm albumin-bound paclitaxel 43Oxaliplatin 42Albumin-Bound Paclitaxel 39Leucovorin 31Erlotinib Hydrochloride 30pembrolizumab 23Radiotherapy 22Irinotecan 22Radiosurgery 20Bevacizumab 19Docetaxel 17Cyclophosphamide 17Taxes 13Cisplatin 13Cetuximab 13folfirinox 12Nivolumab 11Surgical Procedures, Operative 7Paclitaxel 7Ipilimumab 7dehydroftorafur 6Standard of Care 6Radiation 6Magnetic Resonance Spectroscopy 6spartalizumab 5ruxolitinib 5durvalumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Pancreatic Neoplasms × S 1 (combination) × Clear all
NCT00651742 2024-09-19

Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer

Taiho Oncology, Inc.

Phase 2 Completed
28 enrolled 16 charts
Gastrointestinal

Pancreatic Neoplasms

NCT02704143 2020-10-19

Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer

Changhai Hospital

Phase NA Completed
63 enrolled 13 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00429858 2020-09-18

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

University of California, San Francisco

Phase 2 Terminated
21 enrolled 8 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡